RSPRY1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.116400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.646800E-01
Normal-vs-Stage2
8.880200E-01
Normal-vs-Stage3
1.582170E-01
Normal-vs-Stage4
5.644200E-02
Stage1-vs-Stage2
7.983800E-01
Stage1-vs-Stage3
3.550200E-02
Stage1-vs-Stage4
2.458100E-02
Stage2-vs-Stage3
1.377360E-01
Stage2-vs-Stage4
1.418190E-02
Stage3-vs-Stage4
3.801000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.327600E-01
Normal-vs-AfricanAmerican
5.648600E-01
Normal-vs-Asian
6.019400E-01
Caucasian-vs-AfricanAmerican
3.286600E-01
Caucasian-vs-Asian
1.693630E-01
AfricanAmerican-vs-Asian
1.802990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.013800E-01
Normal-vs-Female
9.261000E-01
Male-vs-Female
8.674800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.186600E-01
Normal-vs-Age(41-60Yrs)
5.374800E-01
Normal-vs-Age(61-80Yrs)
9.086600E-01
Normal-vs-Age(81-100Yrs)
6.286800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.452200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.714400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.549400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.156200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.616100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.691200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.114000E-01
Normal-vs-Daily Drinker
5.165800E-01
Normal-vs-Weekly Drinker
7.865800E-01
Normal-vs-Occasional Drinker
7.011400E-01
Normal-vs-Social Drinker
6.100000E-01
Non Drinker-vs-Daily Drinker
3.297200E-01
Non Drinker-vs-Weekly Drinker
8.660400E-01
Non Drinker-vs-Occasional Drinker
1.938440E-01
Non Drinker-vs-Social Drinker
1.494030E-01
Daily Drinker-vs-Weekly Drinker
5.577600E-01
Daily Drinker-vs-Occasional Drinker
5.764300E-02
Daily Drinker-vs-Social Drinker
4.094400E-02
Weekly Drinker-vs-Occasional Drinker
2.684000E-01
Weekly Drinker-vs-Social Drinker
2.133600E-01
Occasional Drinker-vs-Social Drinker
9.255800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.334420E-01
Normal-vs-Grade 2
1.213620E-02
Normal-vs-Grade 3
8.441200E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.569800E-02
Grade 1-vs-Grade 3
8.497700E-03
Grade 1-vs-Grade 4
1.334420E-01
Grade 2-vs-Grade 3
9.314000E-02
Grade 2-vs-Grade 4
1.213620E-02
Grade 3-vs-Grade 4
8.441200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.048600E-01
Normal-vs-NonDiabetic
9.873000E-01
Diabetic-vs-NonDiabetic
4.673200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.173600E-01
Normal-vs-NoPancreatitis
9.793600E-01
Pancreatitis-vs-NoPancreatitis
8.069200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.579400E-01
Normal-vs-N1
8.643000E-01
N0-vs-N1
7.077400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.096200E-01
Normal-vs-TP53-NonMutant
9.140400E-01
TP53-Mutant-vs-TP53-NonMutant
1.687030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
